National Reconnaissance of Pharmaceuticals, Hormones and Other Organic
Wastewater Contaminants in U.S. Streams is Making an Impact
"In 2002, there was no doubt
which article in ES&T
had the most impact: [the USGS Toxics Program report
on emerging contaminants] ... it is truly a remarkable article.
It may prove to be the most cited paper in the history of ES&T. In
the first two weeks following publication (Web release date:
March 13, 2002),
the article had approximately 4000 downloads from the ES&T Website
and was reported by media throughout the world. During the
three months
from July-September, 2002, it still "had legs" with 728 downloads.
In addition, it spawned several Comments and Response to Comments
in ES&T, all with considerable public interest. This represents the
success for which journals, publishers, and scientists all
strive."
-
Jerald L. Schnoor, Editor, Environmental Science and Technology,
in "Making
an
Impact," A
Comment in Environmental Science and Technology, March 2003
|
|
The USGS's National Reconnaissance
of Pharmaceuticals in U.S. Streams is making an impact in the scientific
and regulatory communities.
The paper documented the presence of low levels of many organic wastewater
compounds, including prescription and non-prescription drugs, hormones,
and other wastewater compounds, in a network of 139 targeted streams across
the United States.
More information
- Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams: USGS Fact Sheet FS-027-02
- Pharmaceuticals,
hormones and other organic wastewater contaminants in U.S. streams,
1999-2000--A national reconnaissance: Environmental Science and
Technology, v. 36, no. 6, p. 1202-1211.
- The companion USGS Data report - Water-quality
data for pharmaceuticals, hormones, and other organic wastewater contaminants
in U.S. streams, 1999-2000: USGS Open-File Report 02-94.
- Emerging Contaminants in the Environment Investigation.
- Research on the Environmental Occurrence of Emerging Contaminants
Related Headlines
Return to Headlines Page
|
|